The scope of the scientific activities developed by the groups of the Molecular Biotechnology and Health Area is the understanding of the function displayed by macromolecules as individual entities and as components of more complex systems. This involves genomics, proteomics, and metabolomics approaches, from the purification and characterization of novel proteins, to the use of structural and systems biology analysis to predict the integration of several pathways, or responses to novel drugs. Relevant information is then incorporated into translational projects aiming at novel biotechnological and biomedical applications, in particular drug design and design of new drug carriers.
A common feature of the groups of this area is a deep know-how of a particular set of technologies which is used to tackle specific problems investigated, and which is then made available to other CNC groups. |
